Laurel Savage

Laurel Savage is an accomplished professional in regulatory affairs, currently serving as a Principal Scientist/Director of RA CMC Biologics at Merck. They previously held positions at notable companies including Biovail, Pfizer, LEO Pharma, and Novartis Pharmaceuticals, where they provided strategic direction and documentation for various biological projects. Laurel has a B.S. in Biochemistry from the University of California, Riverside, and is pursuing regulatory affairs education at Medicademy in Copenhagen. Their extensive experience includes establishing regulatory frameworks and leading teams across multiple locations.